VCYT Competitors & Alternatives
Compare Veracyte Inc with similar stocks in the same industry
Diagnostics & Research
VCYT
Main Stock$42.31
Tradestie Score
65
Market Cap
$2.85B
P/E Ratio
29.9
Revenue Growth
0.2%
Analyst Upside
+36.7%
Top Competitors
35 stocks in Diagnostics & Research| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
SHC
Sotera Health Company Common Stock
|
$19.57
|
$4.60B | 33.1 | 46 | Compare |
|
BLLN
BLLN
|
$95.03
|
$4.50B | 128.7 | 68 | Compare |
|
WGS
GeneDx Holdings Corp. Class A Common Stock
|
$87.07
|
$3.26B | - | 39 | Compare |
|
GRAL
GRAIL, Inc. Common Stock
|
$79.54
|
$2.24B | - | 40 | Compare |
|
ADPT
Adaptive Biotechnologies Corporation Common Stock
|
$25.99
|
$2.22B | - | 50 | Compare |
|
TWST
Twist Bioscience Corporation Common Stock
|
$145.59
|
$1.77B | - | 42 | Compare |
|
TXG
10x Genomics, Inc. Class A Common Stock
|
$65.12
|
$1.54B | - | 37 | Compare |
|
NEOG
Neogen Corp
|
$11.95
|
$1.26B | - | 42 | Compare |
|
OPK
Opko Health Inc.
|
$1.48
|
$1.23B | - | 39 | Compare |
|
NEO
NeoGenomics, Inc.
|
$16.98
|
$1.13B | - | 40 | Compare |
More VCYT Analysis
Data updated: Aug 22, 2026 | Industry: Diagnostics & Research (SIC 8071)
35 stocks in this industry